Anika Therapeutics, Inc. (ANIK) Q4 2025 Earnings Call Transcript

Anika Therapeutics, Inc. ( ANIK) Q4 2025 Earnings Call February 26, 2026 8:30 AM EST Good morning, ladies and gentlemen, and welcome to Anika's Fourth Quarter and Year-End Earnings Conference Call.
The BMJ

Adherence to legislation and recommendations to publicly post protocols and results of post-authorisation studies registered with European Medicines Agency: cross sectional study

Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.

Extend Launches CIP: a Cultural Intelligence Platform Empowering Marketers to Plan, Manage, and Monitor Campaigns Directly Through Its Marketing Platform

Extend CIP unifies years of product and agency experience into a single platform for marketers across the Arab world, launching with the region's largest influencer ad library and end-to-end campaign ...